Kathryn A. Phillips, PhD

home / authors / kathryn-a-phillips-phd

Articles

May 9th 2012

Influence of Patient Preferences on the Cost-Effectiveness of Screening for Lynch Syndrome

Grace Wang, PhD, MPH Miriam Kuppermann, PhD, MPH Benjamin Kim, MD, PhD Kathryn A. Phillips, PhD Uri Ladabaum, MD, MS

This cost-utility analysis reports on the effect of quality of life on the value of screening all new patients with colorectal cancer for Lynch Syndrome.

May 18th 2011

Health Technology Assessment and Private Payers's Coverage of Personalized Medicine

Julia R. Trosman, PhD Stephanie L. Van Bebber, MSc Kathryn A. Phillips, PhD

A study of major US private payers showed an important role and considerable shortcomings of external health technology assessment in coverage decisions on personalized medicine.

May 15th 2011

Genomic Testing and Therapies for Breast Cancer in Clinical Practice

Jennifer S. Haas, MD, MSPH Kathryn A. Phillips, PhD Su-Ying Liang, PhD Michael J. Hassett, MD, MPH Carol Keohane, BSN, RN Elena B. Elkin, PhD Joanne Armstrong, MD, MPH Michele Toscano, MS

Despite almost universal testing for human-epidermal-growth-factor-receptor-2 (HER2), many women with a HER2-positive cancer may not receive trastuzumab. Fewer women received the newer gene-expression-profile (GEP) test.

July 1st 2004

Genetic Testing and Pharmacogenomics: Issues for Determining the Impact to Healthcare Delivery and Costs

Kathryn A. Phillips, PhD David L. Veenstra, PharmD, PhD Scott D. Ramsey, MD, PhD Stephanie L. Van Bebber, MSc Julie Sakowski, PhD

June 1st 2004

Willingness to Recommend a Health Plan: Who Is Dissatisfied and What Don't They Like?

Julie A. Sakowski, PhD Kathryn A. Phillips, PhD Su-Ying Liang, PhD Jennifer S. Haas, MD, MSPH

February 1st 2004

Does Patient Cost Sharing Matter? Its Impact on Recommended Versus Controversial Cancer Screening Services

Su-Ying Liang, PhD Kathryn A. Phillips, PhD Sherilyn Tye, PhD Jennifer S. Haas, MD, MSPH Julie Sakowski, PhD